311 related articles for article (PubMed ID: 26316481)
1. The Hematological and Molecular Spectrum of α-Thalassemias in Turkey: The Hacettepe Experience.
Ünal Ş; Gümrük F
Turk J Haematol; 2015 Jun; 32(2):136-43. PubMed ID: 26316481
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Alpha-Thalassemia Mutations in Cases with Hypochromic Microcytic Anemia: The İstanbul Perspective.
Karakaş Z; Koç B; Temurhan S; Elgün T; Karaman S; Asker G; Gençay G; Timur Ç; Yıldırmak ZY; Celkan T; Devecioğlu Ö; Aydın F
Turk J Haematol; 2015 Dec; 32(4):344-50. PubMed ID: 26377141
[TBL] [Abstract][Full Text] [Related]
3. α-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region.
Al-Riyami AZ; Daar S; Kindi SA; Madhani AA; Wali Y; Rawahi MA; Zadjali SA
Hemoglobin; 2020 Jan; 44(1):20-26. PubMed ID: 32019385
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation and molecular identification of four uncommon alpha globin variants in Thailand. Initiation codon mutation of α2-globin Gene (HBA2:c.1delA), donor splice site mutation of α1-globin gene (IVSI-1, HBA1:c.95 + 1G>A), hemoglobin Queens Park/Chao Pra Ya (HBA1:c.98T>A) and hemoglobin Westmead (HBA2:c.369C>G).
Viprakasit V; Ekwattanakit S; Chalaow N; Riolueang S; Wijit S; Tanyut P; Chat-Uthai N; Tachavanich K
Acta Haematol; 2014; 131(2):88-94. PubMed ID: 24081251
[TBL] [Abstract][Full Text] [Related]
5. Molecular spectrum of α-thalassemia mutations in Erbil province of Iraqi Kurdistan.
Shamoon RP
Mol Biol Rep; 2020 Aug; 47(8):6067-6071. PubMed ID: 32712856
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Hb Bart's (γ4) Disease Associated with the - -(THAI) α(0)-Thalassemia Deletion in Mainland China.
Li DZ; Li Y; Li J; Li SC; Li R
Hemoglobin; 2015; 39(6):412-4. PubMed ID: 26212676
[TBL] [Abstract][Full Text] [Related]
7. Screening for common nondeletional α-thalassemias in Chinese newborns by determination of Hb Bart's using the Sebia Capillarys 2 electrophoresis system.
Tang HS; Zhou JY; Xie XM; Li R; Liao C; Li DZ
Hemoglobin; 2012; 36(2):196-9. PubMed ID: 22239481
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Hb levels and degree of anemia in relation to genotype in 615 patients with hemoglobin H disease.
Luo S; Chen X; Chen L; Zhong Q; Wang Q; Xu Z; Huang J; Yan T; Tang N
Expert Rev Hematol; 2020 Sep; 13(9):1027-1033. PubMed ID: 32727230
[TBL] [Abstract][Full Text] [Related]
9. Cord blood screening for alpha-thalassemia and hemoglobin variants by isoelectric focusing in northern Thai neonates: correlation with genotypes and hematologic parameters.
Charoenkwan P; Taweephol R; Sirichotiyakul S; Tantiprabha W; Sae-Tung R; Suanta S; Sakdasirisathaporn P; Sanguansermsri T
Blood Cells Mol Dis; 2010 Jun; 45(1):53-7. PubMed ID: 20299254
[TBL] [Abstract][Full Text] [Related]
10. Novel 31.2 kb α0 Deletion in a Palestinian Family with α-Thalassemia.
Brieghel C; Birgens H; Frederiksen H; Hertz JM; Steenhof M; Petersen J
Hemoglobin; 2015; 39(5):346-9. PubMed ID: 26114741
[TBL] [Abstract][Full Text] [Related]
11. [Alpha 2 codon 30 deletion (deltaGAG) causing non-deletional hemoglobin H disease in Guangxi province].
Chen P; Li SQ; Wu H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):435-9. PubMed ID: 15476164
[TBL] [Abstract][Full Text] [Related]
12. Hb Bart's levels in cord blood and alpha-thalassemia mutations in Cyprus.
Kyriacou K; Kyrri A; Kalogirou E; Vasiliades P; Angastiniotis M; Ioannou PA; Kleanthous M
Hemoglobin; 2000 Aug; 24(3):171-80. PubMed ID: 10975437
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic characteristics of hemoglobin H disease in Iran.
Abolghasemi H; Kamfar S; Azarkeivan A; Karimi M; Keikhaei B; Abolghasemi F; Radfar MH; Eshghi P; Alavi S
Pediatr Hematol Oncol; 2022 Sep; 39(6):489-499. PubMed ID: 34951342
[TBL] [Abstract][Full Text] [Related]
14. Molecular Study of Deletional and Nondeletional Mutations on the α-Globin Locus in the Azeri Population of Northwestern Iran.
Derakhshan SM; Khaniani MS; Afkhami F; PourFeizi AH
Hemoglobin; 2016 Sep; 40(5):319-322. PubMed ID: 27690152
[TBL] [Abstract][Full Text] [Related]
15. Hb H disease: clinical course and disease modifiers.
Fucharoen S; Viprakasit V
Hematology Am Soc Hematol Educ Program; 2009; ():26-34. PubMed ID: 20008179
[TBL] [Abstract][Full Text] [Related]
16. Molecular and clinical features of Hb H disease in northern Thailand.
Charoenkwan P; Taweephon R; Sae-Tung R; Thanarattanakorn P; Sanguansermsri T
Hemoglobin; 2005; 29(2):133-40. PubMed ID: 15921165
[TBL] [Abstract][Full Text] [Related]
17. The relative levels of alpha 2-, alpha 1-, and zeta-mRNA in HB H patients with different deletional and nondeletional alpha-thalassemia determinants.
Smetanina NS; Oner C; Baysal E; Oner R; Bozkurt G; Altay C; Gürgey A; Adekile AD; Gu LH; Huisman TH
Biochim Biophys Acta; 1996 Aug; 1316(3):176-82. PubMed ID: 8781536
[TBL] [Abstract][Full Text] [Related]
18. Hb Westmead (
Jiang F; Ju AP; Li J; Chen GL; Zhou JY; Tang XW; Zuo LD; Li DZ
Hemoglobin; 2020 May; 44(3):153-155. PubMed ID: 32436451
[TBL] [Abstract][Full Text] [Related]
19. A stepwise α-thalassemia screening strategy in high-prevalence areas.
Alkindi SS; Alzadjali S; Daar S; Sindhuvi E; Wali Y; Pathare AV; Venugopal S; Lapoumeroulie C; Srivastava A; Krishnamoorthy R
Eur J Haematol; 2013 Aug; 91(2):164-9. PubMed ID: 23668236
[TBL] [Abstract][Full Text] [Related]
20. Molecular Characterization of Hb H and AEBart’s Diseases in Thai Children: Phramongkutklao Hospital Experiences.
Boonyawat B; Photia A; Monsereenusorn C; Rujkijyanont P; Traivaree C
J Med Assoc Thai; 2017 Feb; 100(2):167-74. PubMed ID: 29916623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
